Straumann Holding AG (STMN.S)

STMN.S on Swiss Exchange

11:30am EST
Price Change (% chg)

CHF3.60 (+1.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for STMN.S


Straumann Holding AG is a Switzerland-based company, member of the Straumann Group, active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturi... (more)


Beta: 0.50
Market Cap (Mil.): CHF3,798.43
Shares Outstanding (Mil.): 15.68
Dividend: 3.75
Yield (%): 1.55


  STMN.S Industry Sector
P/E (TTM): 32.87 33.36 37.24
EPS (TTM): 7.37 -- --
ROI: 13.04 10.81 18.21
ROE: 18.48 12.64 19.11
Search Stocks

BRIEF-Straumann CFO sees 2014 EBIT margin between 20 and 21 pct

* CFO expects an EBIT margin for 2014 between 20 and 21 percent Further company coverage:

23 Oct 2014

UPDATE 2-Straumann lifts full-year outlook after strongest sales growth in 15 quarters

* Q3 sales rise 7.3 pct to 164.3 mln Sfr vs 158 mln f'cast

23 Oct 2014

BRIEF-Straumann opens 2.7 pct higher after Q3 sales beat

* Shares in Straumann rise 2.7 pct after raises full-year guidance; third-quarter sales beat Further company coverage:

23 Oct 2014

BRIEF-Straumann CEO says pleased with developments in Oct

* CEO says pleased with developments in Oct; no signs growth momentum coming to an end

23 Oct 2014

Straumann lifts full-year outlook as Q3 sales beat forecasts

ZURICH, Oct 23 - Straumann Holding AG, the world's largest maker of dental implants, raised its full-year sales and profit outlook on Thursday as third-quarter revenue beat expectations, helped by strong growth in the United States, China and Japan.

23 Oct 2014

UPDATE 2-Straumann passes on Nobel Biocare, eyes China instead

* H1 net profit 69 mln Sfr vs 65 mln Sfr forecast (Adds CEO comments, shares, background)

26 Aug 2014

Straumann first-half sales rise as marketing push pays off

ZURICH, Aug 26 - Straumann, the world's largest maker of dental implants, confirmed its full-year guidance on Tuesday as a new marketing push and pricing strategy helped underlying sales grow 4.6 percent in the first half.

26 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Directors Deals Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks